Get the Stockscreener App
3.43
5.77%
-0.21
Nephros Inc stock is traded at $3.43, with a volume of 7,992.
It is down -5.77% in the last 24 hours and down -4.99% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
See More
Previous Close:
$3.64
Open:
$3.65
24h Volume:
7,992
Relative Volume:
0.42
Market Cap:
$37.24M
Revenue:
$19.12M
Net Income/Loss:
$776.00K
P/E Ratio:
48.58
EPS:
0.0706
Net Cash Flow:
$-348.00K
1W Performance:
-6.79%
1M Performance:
-4.99%
6M Performance:
-22.57%
1Y Performance:
-3.92%
1-Day Range:
$3.3987
$3.65
1-Week Range:
$3.3987
$3.85
52-Week Range:
$2.6629
$6.42
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Compare NEPH vs PSNYW, GOODO, SHMD, DWLD, QQQE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.84 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
2.5899 | 404.28M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.44 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
4.29 | 270.26M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.45 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
116.30 | 0 | 0 | 0 | 0 | 0.00 |
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Nephros Inc (NEPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
NEPH|Nephros Inc|Price:3.640|Chg%:-0.130 - TradingKey
Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nephros Inc (NEPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Nephros Inc (NEPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nephros Inc (NEPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nephros to Present at Maxim Group’s “Health, Wellness & Longevity” Virtual Summit on July 22, 2026 - Quiver Quantitative
Nephros to Participate in the 'Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET - The Manila Times
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET - GlobeNewswire Inc.
Nephros added to Russell Microcap Index - MSN
Northland Securities Initiates Coverage on Nephros With Market Perform Rating, $4 Price Target - Moomoo
Nephros | 8-K: Current report - Moomoo
Northland initiates Nephros stock coverage with $4 price target By Investing.com - Investing.com South Africa
Northland Securities Initiates Nephros(NEPH.US) With Hold Rating, Announces Target Price $4 - Moomoo
Northland initiates Nephros stock coverage with $4 price target - Investing.com
Nephros Inc. (NEPH) Q1 2026 Earnings: EPS Misses Estimate by Narrow Margin, Stock DeclinesProfit Recovery Report - dars.gov.et
Nephros Inc. (NEPH) Gains 3.7% as Shares Test Key Resistance Near $3.81Keltner Channel - dars.gov.et
Price to sales forward of Nephros, Inc. – NASDAQ:NEPH - TradingView
Price to book forward of Nephros, Inc. – NASDAQ:NEPH - TradingView
Nephros Announces Inclusion in the Russell Microcap Index - marketscreener.com
Enterprise value to revenue forward of Nephros, Inc. – NASDAQ:NEPH - TradingView
NEPH Q1 2026 Earnings: Near Break-Even Performance Amid Cost DisciplineEarnings Momentum Score - DonanımHaber
Nephros added to Russell Microcap Index By Investing.com - Investing.com Nigeria
Nephros Announces Inclusion in the Russell Microcap® Index - The Manila Times
Nephros joins Russell Microcap Index after annual reconstitution - Stock Titan
Nephros Inc. (NEPH) Edges Higher Amid Steady Trading — Key Levels in FocusUndervalued Stocks - dars.gov.et
Nephros, Inc.(NasdaqCM: NEPH) added to Russell 3000E Index - marketscreener.com
Nephros, Inc.(NasdaqCM: NEPH) added to Russell 3000E Growth Benchmark - marketscreener.com
Nephros, Inc.(NasdaqCM: NEPH) added to Russell Microcap Index - marketscreener.com
Nephros, Inc.(NasdaqCM: NEPH) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Nephros | 4: Statement of changes in beneficial ownership of securities-Officer Banks Robert R. Jr. - Moomoo
Nephros Bets on Services Over Sales: A Deeper Dive Into its 'Beyond Filtration' Play - BriefGlance
Nephros to Host Virtual Investor Event: 'Beyond Filtration: The Nephros Model in Action” - The Manila Times
Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action” - Caledonian Record
Nephros pitches a model beyond filtration at July 16 event - Stock Titan
NEPHNephros Inc Volatility & Greeks - Finviz
Why Is Nephros Drawing Attention In The Water Filtration Industry? - Kalkine Media
Nephros Inc (NEPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nephros Inc (NEPH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nephros Inc (NEPH) Institutional Confidence - TradingKey
Nephros Inc (NEPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nephros highlights filtration technology for microplastics removal By Investing.com - Investing.com Nigeria
Nephros highlights filtration technology for microplastics removal - Investing.com
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water - The Globe and Mail
NEPH Q1 2026 Earnings: EPS Falls Just Short of Expectations, Stock Declines 6.3%Earnings Preview - newsline.com
Nephros posts updated 2026 corporate presentation on website - TradingView
Nephros Inc. (NEPH) Holds Steady Near Support After Modest GainNAAIM Leverage - newsline.com
Nephros (NEPH) director awarded 3,574 shares and holds options expiring 2034–2035 - Stock Titan
Nephros (NASDAQ: NEPH) posts updated 2026 corporate presentation online - Stock Titan
NEPH Q1 2026 Earnings: EPS Slightly Misses Estimates, Stock DeclinesSpecial Dividend Alert - newsline.com
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):